niglumine 50ml

niglumine 50ml in the treatment of visceral pain associated with colic and in the treatment of inflammation and pain associated with muscrders.uloskeletal diso

niglumine 50ml is recommended in those cases where corticosteroid therapy is contraindicated

DOSAGE AND HOW TO USE

niglumine 50ml  should be administered to cattle and horses intramuscularly.
Cattle:  1mL for each 22.5 kg of weight intramuscularly or intravenously. Repeat if necessary, at intervals of 24 hours, but not more than 5 consecutive days.
Horses:  In visceral pain associated with colic, 1mL is recommended for every 45 kg of weight intramuscularly or intravenously, at the onset of symptoms. Treatment can be repeated 1 or 2 times if symptoms reappear.
In inflammation and pain associated with musculoskeletal changes, 1 ml is recommended for every 45 kg of weight, intramuscularly or intravenously, once a day for no more than 5 consecutive days.

PRECAUTIONS niglumine 50ml

Do not exceed recommended serving. Do not mix other substances in the same syringe. Avoid intra-arterial injection to horses, as they react with ataxia, incoordination, hyperventilation, hysteria and muscle weakness. Precautions should be taken when administering to calves and, if symptoms of dehydration occur, fluid therapy should be performed. Do not use during pregnancy.

Do not use in animals less than 3 days old. Do not use in horses with a history of hypersensitivity to flunixin.

WITHDRAWAL PERIOD
Cattle: Slaughter: slaughter of animals treated with this product should only be carried out 20 days after the last application. Milk: Milk from animals treated with this product must not be destined for human consumption until 1 day after the last application of this product.
Horses: Slaughter: Do not use in animals whose meat is intended for human consumption.

PRESENTATIONS
Glass vial containing 50 mL.

WITHDRAWAL PERIOD
Cattle: Slaughter: slaughter of animals treated with this product should only be carried out 20 days after the last application. Milk: Milk from animals treated with this product must not be destined for human consumption until 1 day after the last application of this product.
Horses: Slaughter: Do not use in animals whose meat is intended for human Do not exceed recommended serving. Do not mix other substances in the same syringe. Avoid intra-arterial injection to horses, as they react with ataxia, incoordination, hyperventilation, hysteria and muscle weakness. Precautions should be taken when administering to calves and, if symptoms of dehydration occur, fluid therapy should be performed. Do not use during pregnancy